1
|
Ito M, Hiramatsu H, Kobayashi K, Suzue K,
Kawahata M, Hioki K, Ueyama Y, Koyanagi Y, Sugamura K, Tsuji K,
Heike T and Nakahata T: NOD/SCID/gamma(c)(null) mouse: an excellent
recipient mouse model for engraftment of human cells. Blood.
100:3175–3182. 2002. View Article : Google Scholar : PubMed/NCBI
|
2
|
Suemizu H, Monnai M, Ohnishi Y, Ito M,
Tamaoki N and Nakamura M: Identification of a key molecular
regulator of liver metastasis in human pancreatic carcinoma using a
novel quantitative model of metastasis in NOD/SCID/γcnull (NOG)
mice. Int J Oncol. 31:741–751. 2007.PubMed/NCBI
|
3
|
Ruers T and Bleichrodt RP: Treatment of
liver metastases, an update on the possibilities and results. Eur J
Cancer. 38:1023–1033. 2002. View Article : Google Scholar : PubMed/NCBI
|
4
|
Khatib AM, Fallavollita L, Wancewicz EV,
Monia BP and Brodt P: Inhibition of hepatic endothelial E-selectin
expression by C-raf antisense oligonucleotides blocks colorectal
carcinoma liver metastasis. Cancer Res. 62:5393–5398. 2002.
|
5
|
Hamada K, Monnai M, Kawai K, Nishime C,
Miyazaki N, Ohnishi Y, Nakamura M and Suemizu H: Liver metastasis
models of colon cancer for evaluation of drug efficacy using
NOD/Shi-scid IL2Rγnull (NOG) mice. Int J Oncol. 32:153–159.
2008.PubMed/NCBI
|
6
|
Abu-Eid R and Landini G: Morphometrical
differences between pseudo-epitheliomatous hyperplasia in granular
cell tumors and squamous cell carcinomas. Histopathology.
48:407–416. 2006. View Article : Google Scholar : PubMed/NCBI
|
7
|
Soga T, Baran R, Suematsu M, Ueno Y, Ikeda
S, Sakurakawa T, Kakazu Y, Ishikawa T, Robert M, Nishioka T and
Tomita M: Differential metabolomics reveals ophthalmic acid as an
oxidative stress biomarker indicating hepatic glutathione
consumption. J Biol Chem. 281:16768–16776. 2006. View Article : Google Scholar
|
8
|
Frieboes HB, Zheng X, Sun CH, Tromberg B,
Gatenby R and Cristini V: An integrated computational/experimental
model of tumor invasion. Cancer Res. 66:1597–1604. 2006. View Article : Google Scholar : PubMed/NCBI
|
9
|
Lee H, Lin EC, Liu L and Smith JW: Gene
expression profiling of tumor xenografts: in vivo analysis of
organ-specific metastasis. Int J Cancer. 107:528–534. 2003.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Leth-Larsen R, Lund R, Hansen HV,
Laenkholm AV, Tarin D, Jensen ON and Ditzel HJ: Metastasis-related
plasma membrane proteins of human breast cancer cells identified by
comparative quantitative mass spectrometry. Mol Cell Proteomics.
8:1436–1449. 2009. View Article : Google Scholar : PubMed/NCBI
|
11
|
Gallagher SM, Castorino JJ, Wang D and
Philp NJ: Monocarboxylate transporter 4 regulates maturation and
trafficking of CD147 to the plasma membrane in the metastatic
breast cancer cell line MDA-MB-231. Cancer Res. 67:4182–4189. 2007.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Saleem M, Kweon MH, Johnson JJ, Adhami VM,
Elcheva I, Khan N, Bin Hafeez B, Bhat KM, Sarfaraz S, Reagan-Shaw
S, Spiegelman VS, Setaluri V and Mukhtar H: S100A4 accelerates
tumorigenesis and invasion of human prostate cancer through the
transcriptional regulation of matrix metalloproteinase 9. Proc Natl
Acad Sci USA. 103:14825–14830. 2006. View Article : Google Scholar : PubMed/NCBI
|
13
|
Salaun B, Coste I, Rissoan MC, Lebecque SJ
and Renno T: TLR3 can directly trigger apoptosis in human cancer
cells. J Immunol. 176:4894–4901. 2006. View Article : Google Scholar : PubMed/NCBI
|
14
|
Moreb JS, Baker HV, Chang LJ, Amaya M,
Lopez MC, Ostmark B and Chou W: ALDH isozymes downregulation
affects cell growth, cell motility and gene expression in lung
cancer cells. Mol Cancer. 7:872008. View Article : Google Scholar : PubMed/NCBI
|
15
|
Tokunaga T, Oshika Y, Abe Y, Ozeki Y,
Sadahiro S, Kijima H, Tsuchida T, Yamazaki H, Ueyama Y, Tamaoki N
and Nakamura M: Vascular endothelial growth factor (VEGF) mRNA
isoform expression pattern is correlated with liver metastasis and
poor prognosis in colon cancer. Br J Cancer. 77:998–1002. 1998.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Brabletz T, Jung A, Spaderna S, Hlubek F
and Kirchner T: Opinion: migrating cancer stem cells – an
integrated concept of malignant tumour progression. Nat Rev Cancer.
5:744–749. 2005.PubMed/NCBI
|
17
|
Cho SY, Polster L, Engles JM, Hilton J,
Abraham EH and Wahl RL: In vitro evaluation of adenosine
5′-monophosphate as an imaging agent of tumor metabolism. J Nucl
Med. 47:837–845. 2006.
|
18
|
Takedachi M, Qu D, Ebisuno Y, Oohara H,
Joachims ML, McGee ST, Maeda E, McEver RP, Tanaka T, Miyasaka M,
Murakami S, Krahn T, Blackbum MR and Thompson LF: CD73-generated
adenosine restricts lymphocyte migration into draining lymph nodes.
J Immunol. 180:6288–6296. 2008. View Article : Google Scholar : PubMed/NCBI
|
19
|
Hasko G, Szabo C, Nemeth ZH, Kvetan V,
Pastores SM and Vizi ES: Adenosine receptor agonists differentially
regulate IL-10, TNF-α and nitric oxide production in RAW 264.7
macrophages and in endotoxemic mice. J Immunol. 157:4634–4640.
1996.PubMed/NCBI
|
20
|
Zhou X, Zhi X, Zhou P, Chen S, Zhao F,
Shao Z, Ou Z and Yin L: Effects of ecto-5′-nucleotidase on human
breast cancer cell growth in vitro and in vivo. Oncol
Rep. 17:1341–1346. 2007.
|